Hasil Pencarian - R. Ramchandren
- Menampilkan 1 - 4 hasil dari 4
-
1
P1121: TAKEAIM LYMPHOMA- AN OPEN-LABEL, DOSE ESCALATION AND EXPANSION TRIAL OF EMAVUSERTIB (CA-4948) IN COMBINATION WITH IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOG... oleh E. Joffe, G. Nowakowski, H. Tun, A. Rosenthal, M. Lunning, R. Ramchandren, C.-C. Li, L. Zhou, E. Martinez, R. von Roemeling, R. Earhart, M. McMahon, I. Isufi, L. Leslie
Diterbitkan 2022-06-01
Artikel -
2
PB1820: CD47-BLOCKER TTI-622 COMBINED WITH AZACITIDINE IN PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA (AML) AND WITH AZACITIDINE + VENETOCLAX IN ELDERLY OR UNFIT PATIENTS WIT... oleh N. Daver, M. Maris, R. Ramchandren, D. Bixby, K. Doucette, R. Mawad, D. Egan, D. Stevens, J. Zonder, N. Molloy, A. Scheuber, I. Bruns, I. Mantzaris, M. Konopleva, A. D. Goldberg
Diterbitkan 2022-06-01
Artikel -
3
S200: IMPROVED OVERALL SURVIVAL WITH FIRST-LINE BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY IN PATIENTS WITH STAGE III/IV CLASSICAL HODGKIN LYMPHOMA: 6-YEAR ANALYSIS OF ECHELON-1 oleh M. Hutchings, S. M. Ansell, D. J. Straus, J. M. Connors, W. S. Kim, A. Gallamini, R. Ramchandren, J. W. Friedberg, R. Advani, A. M. Evens, P. Smolewski, K. J. Savage, N. L. Bartlett, H.-S. Eom, J. S. Abramson, C. Dong, F. Campana, K. Fenton, M. Puhlmann, J. Radford
Diterbitkan 2022-06-01
Artikel -
4
P1089: BRENTUXIMAB VEDOTIN, NIVOLUMAB, DOXORUBICIN, AND DACARBAZINE (AN+AD) FOR ADVANCED STAGE CLASSIC HODGKIN LYMPHOMA: PRELIMINARY SAFETY AND EFFICACY RESULTS FROM THE PHASE 2 ST... oleh H. Lee, I. W. Flinn, J. Melear, R. Ramchandren, J. Friedman, J. M. Burke, Y. Linhares, M. Raval, R. Chintapatla, T. A. Feldman, H. Yimer, M. Islas-Ohlmayer, A. Dean, V. Rana, M. D. Gandhi, J. Renshaw, A. L. Gillespie-Twardy, L. Ho, M. Puhlmann, W. Guo, C. A. Yasenchak
Diterbitkan 2022-06-01
Artikel